| Entry |
|
| Name |
Fispemifene (USAN/INN) |
| Formula |
C26H27ClO3
|
| Exact mass |
422.1649
|
| Mol weight |
422.94
|
| Structure |

|
| Simcomp |
|
| Class |
Hormonal agent
DG01619 Estrogen receptor antagonist/modulator
DG01621 Selective estrogen receptor modulator
|
| Efficacy |
Osteoporosis agent, Estrogen receptor agonist/antagonist |
| Comment |
Selective estrogen receptor modulators (SERMs)
Male hypogonadism, male urinary tract symptoms
|
| Target |
|
| Pathway |
| hsa04961 | Endocrine and other factor-regulated calcium reabsorption |
|
| Brite |
Drug groups [BR:br08330]
Hormonal agent
DG01619 Estrogen receptor antagonist/modulator
DG01621 Selective estrogen receptor modulator
D10008 Fispemifene
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Estrogen like receptors
Estrogen receptor
NR3A (ESR)
D10008 Fispemifene (USAN/INN)
|
| Other DBs |
|
| LinkDB |
|
| KCF data |
ATOM 30
1 C1b C 16.7300 -18.1300
2 C2c C 17.9424 -18.8300
3 C1b C 15.5176 -18.8300
4 X Cl 14.3221 -18.1396
5 C8y C 19.1379 -18.1396
6 C2c C 17.9425 -20.2298
7 C8y C 19.1381 -20.9202
8 C8y C 16.7132 -20.9397
9 C8x C 15.5092 -20.2446
10 C8x C 14.2968 -20.9447
11 C8x C 14.2968 -22.3447
12 C8x C 15.5008 -23.0398
13 C8x C 16.7133 -22.3397
14 C8x C 19.1382 -22.3297
15 C8x C 20.3507 -23.0296
16 C8y C 21.5630 -22.3295
17 C8x C 21.5629 -20.9200
18 C8x C 20.3504 -20.2201
19 C8x C 20.3253 -18.8251
20 C8x C 21.5377 -18.1250
21 C8x C 21.5376 -16.7250
22 C8x C 20.3503 -16.0396
23 C8x C 19.1379 -16.7396
24 O2a O 22.7735 -23.0282
25 C1b C 23.9674 -22.3386
26 C1b C 25.1556 -23.0245
27 O2a O 26.3463 -22.3367
28 C1b C 27.5361 -23.0235
29 C1b C 28.7260 -22.3362
30 O1a O 29.9163 -23.0233
BOND 32
1 1 2 1
2 1 3 1
3 3 4 1
4 2 5 1
5 2 6 2
6 6 7 1
7 6 8 1
8 8 9 2
9 9 10 1
10 10 11 2
11 11 12 1
12 12 13 2
13 8 13 1
14 7 14 2
15 14 15 1
16 15 16 2
17 16 17 1
18 17 18 2
19 7 18 1
20 5 19 2
21 19 20 1
22 20 21 2
23 21 22 1
24 22 23 2
25 5 23 1
26 16 24 1
27 24 25 1
28 25 26 1
29 26 27 1
30 27 28 1
31 28 29 1
32 29 30 1
|